Literature DB >> 30080930

Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Thinzar M Lwin1, Robert M Hoffman1,2, Michael Bouvet1,3.   

Abstract

Fluorescence-guided surgery can enhance the surgeon's ability to achieve a complete oncologic resection. There are a number of tumor-specific probes being developed with many preclinical mouse models to evaluate their efficacy. The current review discusses the different preclinical mouse models in the setting of probe evaluation and highlights the advantages of patient-derived orthotopic xenografts (PDOX) mouse models and genetic reporters to develop fluorescence-guided surgery.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  fluorescence-guided surgery (FGS); genetic reporters; patient-derived orthotopic xenografts (PDOX); preclinical mouse models; surgical orthotopic implantation (SOI)

Mesh：

Substances：

Year:  2018        PMID： 30080930      PMCID： PMC6146062          DOI： 10.1002/jso.25150

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  105 in total

1.  Development and application of the near-infrared and white-light thoracoscope system for minimally invasive lung cancer surgery.

Authors:  Yamin Mao; Kun Wang; Kunshan He; Jinzuo Ye; Fan Yang; Jian Zhou; Hao Li; Xiuyuan Chen; Jun Wang; Chongwei Chi; Jie Tian
Journal:  J Biomed Opt       Date:  2017-06-01       Impact factor: 3.170

Review 2.  Telomerase activity in human cancer.

Authors:  J W Shay; W E Wright
Journal:  Curr Opin Oncol       Date:  1996-01       Impact factor: 3.645

3.  High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.

Authors:  Michael Bouvet; Joseph Spernyak; Matthew H Katz; Richard V Mazurchuk; Shinako Takimoto; Ralph Bernacki; Youcef M Rustum; Abdool R Moossa; Robert M Hoffman
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

4.  Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer.

Authors:  J Sven D Mieog; Merlijn Hutteman; Joost R van der Vorst; Peter J K Kuppen; Ivo Que; Jouke Dijkstra; Eric L Kaijzel; Frans Prins; Clemens W G M Löwik; Vincent T H B M Smit; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  Breast Cancer Res Treat       Date:  2010-09-07       Impact factor: 4.872

5.  Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.

Authors:  B M Stiles; P S Adusumilli; A Bhargava; S F Stanziale; T H Kim; M-K Chan; R Huq; R Wong; V W Rusch; Y Fong
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

6.  Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors.

Authors:  Meng Yang; Jose Reynoso; Ping Jiang; Lingna Li; Abdool R Moossa; Robert M Hoffman
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

7.  uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Authors:  Lily Yang; Hari Krishna Sajja; Zehong Cao; Weiping Qian; Laura Bender; Adam I Marcus; Malgorzata Lipowska; William C Wood; Y Andrew Wang
Journal:  Theranostics       Date:  2013-12-17       Impact factor: 11.556

8.  Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.

Authors:  Quirijn R J G Tummers; Charlotte E S Hoogstins; Katja N Gaarenstroom; Cor D de Kroon; Mariette I E van Poelgeest; Jaap Vuyk; Tjalling Bosse; Vincent T H B M Smit; Cornelis J H van de Velde; Adam F Cohen; Philip S Low; Jacobus Burggraaf; Alexander L Vahrmeijer
Journal:  Oncotarget       Date:  2016-05-31

9.  Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.

Authors:  Shuya Yano; Kiyoto Takehara; Shinji Miwa; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-11-15

10.  Manifestation of metastatic potential in human gastric cancer implanted into the stomach wall of nude mice.

Authors:  T Yamashita
Journal:  Jpn J Cancer Res       Date:  1988-08
View more
  10 in total

1.  Assessment of human pancreas cancer tissue and precursor lesions via a fluorophore with inherent PDAC selectivity.

Authors:  Ian R Munhenzva; Connor W Barth; Martha Sibrian-Vazquez; Lei G Wang; Jorge O Escobedo; Summer L Gibbs; Robert M Strongin
Journal:  Methods       Date:  2019-06-08       Impact factor: 3.608

2.  Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.

Authors:  Thinzar M Lwin; Michael A Turner; Hiroto Nishino; Siamak Amirfakhri; Sophie Hernot; Robert M Hoffman; Michael Bouvet
Journal:  Biomolecules       Date:  2022-05-16

3.  CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.

Authors:  Katrin Kleinmanns; Vibeke Fosse; Ben Davidson; Elvira García de Jalón; Olav Tenstad; Line Bjørge; Emmet McCormack
Journal:  EBioMedicine       Date:  2020-05-23       Impact factor: 8.143

Review 4.  T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges.

Authors:  Dalia Haydar; Jorge Ibañez-Vega; Giedre Krenciute
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

5.  Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice.

Authors:  Diana Yuzhakova; Elena Kiseleva; Marina Shirmanova; Vladislav Shcheslavskiy; Daria Sachkova; Ludmila Snopova; Evgeniya Bederina; Maria Lukina; Varvara Dudenkova; Gaukhar Yusubalieva; Tatyana Belovezhets; Daria Matvienko; Vladimir Baklaushev
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

Review 6.  Overcoming biological barriers to improve solid tumor immunotherapy.

Authors:  Anvay Ukidve; Katharina Cu; Ninad Kumbhojkar; Joerg Lahann; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

Review 7.  Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

Authors:  Asbiel Hasbum; Jaqueline Quintanilla; Juan A Amieva Jr; May-Hui Ding; Arkene Levy; Sue Anne Chew
Journal:  Future Med Chem       Date:  2021-01-05       Impact factor: 3.808

Review 8.  Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies.

Authors:  Gabriel Silva Marques Borges; Eduardo Burgarelli Lages; Pierre Sicard; Lucas Antônio Miranda Ferreira; Sylvain Richard
Journal:  Front Cardiovasc Med       Date:  2021-06-30

Review 9.  Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.

Authors:  Qiang Li; Heng Dong; Guangwen Yang; Yuxian Song; Yongbin Mou; Yanhong Ni
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

Review 10.  Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.

Authors:  Thinzar M Lwin; Michael A Turner; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Michael Bouvet
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.